The ideal candidate will have experience as a beat reporter covering both the business and politics of health care and will already be based in Washington. Experience covering Congress and/or the FDA is a plus.
STAT covers a range of issues debated in D.C., with a particular emphasis on drug pricing, biomedical research funding and the pharmaceutical industry’s influence in Washington.
We’re looking for a flexible reporter who can break news and deliver quick-turn analyses, including for our subscription product, STAT Plus, but also conceive of and execute illuminating, provocative and unexpected enterprise stories. Our Washington reporters are a small but close-knit team, reporting to an editor based in our Boston headquarters.
STAT is a startup, so collaborative spirit, initiative and a willingness to innovate are essential. Also essential: Fidelity to bedrock journalistic values and a commitment to excellence.
STAT is affiliated with Boston Globe Media but is independent from The Boston Globe.
CNBC senior vice president Dan Colarusso sent out the following on Monday: Before this year comes to…
Business Insider editor in chief Jamie Heller sent out the following on Monday: I'm excited to share…
Former CoinDesk editorial staffer Michael McSweeney writes about the recent happenings at the cryptocurrency news site, where…
Manas Pratap Singh, finance editor for LinkedIn News Europe, has left for a new opportunity…
Washington Post executive editor Matt Murray sent out the following on Friday: Dear All, Over the last…
The Financial Times has hired Barbara Moens to cover competition and tech in Brussels. She will start…